Auger-electron spectra of radionuclides for theraphy and diagnostics

Acta Oncologica

Volumn 35, Issue 7, 1996, Pages 863-868

  Stepanek, Jiri ^a,b   Larsson, Börje ^a   Weinreich, Regin ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOSIMETRY; ELECTRON EMISSION; ONCOLOGY; RADIATION EFFECTS; RADIOTHERAPY;

AUGER ELECTRONS; ELECTRON EMITTING RADIONUCLIDES;

RADIOISOTOPES;

ASTATINE 211; BROMINE 77; BROMINE 80M; CHROMIUM 51; COPPER 64; GALLIUM 67; INDIUM 114M; IODINE 123; IODINE 124; IODINE 125; PLATINUM 193M; PLATINUM 195M; SELENIUM 73; SELENIUM 75; TECHNETIUM 94; TECHNETIUM 99M; THULIUM 167; UNCLASSIFIED DRUG;

AUGER ELECTRON SPECTROSCOPY; CONFERENCE PAPER; CONTROLLED STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DECAY; RADIOISOTOPE THERAPY; SCINTISCANNING; SPECTROMETRY;

HALF-LIFE; LINEAR ENERGY TRANSFER; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIOISOTOPES;

EID: 0030449546     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609104038     Document Type: Article

References (32)

1. Snyder WS. Absorbed dose per unit cumulated activity for selected radionuclides and organs. NM/MIRD Pamphlet No. 11, New York: Society of Nuclear Medicine, 1975.
2. Loevinger R, Budinger TF, Watson EE, in collaboration with MIRD committee. MIRD primer for absorbed dose calculations. New York: Society of Nuclear Medicine, 1980.
3. Task Group Committee 2 of the International Commission on Radiological Protection: Radiation Dose to Patients from Radiopharmaceuticals, ICRP Publication No. 53, Oxford, Pergamon Press, 1988.
4. Atkins HL. Potential future application with therapeutic agents. Semin Nucl Med 1979; 9: 121.
5. Adelstein SJ, Kassis AI. Radiobiological implications of the microscopic distribution of energy from radionuclides. Nucl Med Biol 1987; 14: 165.
6. Howell RW. The MIRD scheme: From organ to cellular dimension. J Nucl Med 1993; 35: 531.
7. Rao DV, Nara VR, Howell RW, Govelitz GF, Sastry KS. In-vivo radiotoxicity of DNA-incorporated I-125 compared with that of densely ionizing alpha-particles. Lancet 1989; 2: 650-3.
8. Martin RF, Haseltine WA. Range of radiochemical damage to DNA with decay of iodine-125. Science 1981; 213: 896.
9. 125I-labelled DNA ligand to probe DNA structure. Nature 1983; 302: 452.
10. Martin RF, Murray V, D'Cunha G, et al. Radiation sensitization by an iodine-labelled DNA ligand. Int J Radiat Biol 1990; 57: 939.
11. Humm JL, Cobb LM. Nonuniformity of tumor dose in radioimmunotherapy. J Nucl Med 1990; 31: 75.
12. Bardiès M, Myers MJ. A simplified approach to alpha dosimetry for small spheres labelled on the surface. Phys Med Biol 1990; 35: 1551.
13. Humm JL, Chin LM. A model of cell inactivation by alpha-particle internal emitters. Radiat Res 1993; 134: 143.
14. Howell RW. Radiation spectra for Auger-electron emitting radionuclides; Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1992; 19: 1371.
15. Howell RW, Rao DV, Hou DY, Narra VR, Sastry KS. The question of relative biological effectiveness and quality factor for Auger emitters incorporated into proliferating mammalian cells. Radiat Res 1991; 128: 128.
16. Mausner LF, Srivastava SC. Selection of radionuclides for radioimmunotherapy. Med Phys 1993; 20: 503.
17. 195mPt-cis-dichlorodiammine platinum (II) in man. J Nucl Med 1974; 15: 349.
18. Thatcher N, Sharma H, Harrison R, et al. Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis,trans-dichlorodihydroxy-bis-(isopropylamine)platinum IV and cis-dichloro-bis-cyclopropylamine platinum II in patients with malignant disease. Cancer Chemother Pharmacol 1982; 9: 13.
19. Los G, Mutsaen PHA, Lengler WJM, et al. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol 1990; 25: 389.
20. 195mPt]cis-platin suitable for clinical studies. Appl Rad Isotopes 1992; 43: 809.
21. Bigler RE, Zanzonico PB. Adjutant radioimmunotherapy for micrometastases. Srivastava SC, ed. Radiolabeled monoclonal antibodies for imaging and therapy. In: Plenum, New York; 1988: 409.
22. McLaughlin WH, Thramann Jr WM, Lambrecht RM, Milius RA, Bloomer WD. Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosine. J Surg Oncol 1988; 37: 192.
23. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: Treatment of cutaneous tumors and lymph node metastases. Cancer Res 1992; 52: 4385.
24. Stepanek J. A method to determine the radiation spectra due to a single atomic-subshell ionization by a particle or due to decay of radionuclides. Proceedings of SGSMP/SGBT-annual meeting, Villigen, Switzerland, 1993.
25. Stepanek J. A program to determine the radiation spectra due to a single atomic-subshell ionisation by a particle or due to de-excitation or decay of radionuclides. Comp Phys Comm (accepted for publication).
26. Tuli JK. Evaluated nuclear structure data file. Brookhaven National Laboratory report BNL-NCS-51655-Rev. 87, 1987.
27. Cullen DE, Perkins ST. The 1991 Livermore evaluated atomic data library (EADL). Lawrence Livermore National Laboratory, Livermore, CA, (to be published).
28. 125I Auger cascades and of the associated radiation chemistry in aqueous solution. Radiat Prot Dosim 1994; 52: 177.
29. Knespl D, Reist HW, Stepanek J. Particle track simulation in nanometer range for radiotherapy and radiation protection. Proceedings of SGSMP/SGBT-Annual meeting, Villigen, Switzerland, 1993.
30. GEANT Team, GEANT Version 315, Cern-Data Handling Division, DD/EE/84-1, Revision, 1992.
31. Cullen DE, Perkins ST, Rathkopf JA. The 1989 Livermore evaluated photon data library (EPDL). Lawrence Livermore National Laboratory. Livermore, CA, Report UCRL-ID-103424, 1990.
32. Perkins ST, Cullen DE, Seltzer SM. Tables and graphs of electron-interaction cross sections from 10 eV to 100 GeV derived from LLNL evaluated nuclear data library (ENDL), Z=1 100. Lawrence Livermore ational Laboratory, Livermore, CA, Report UCRL-50400, Vol. 31, 1991.